401k Plan data: AGRELIANT GENETICS 401K RETIREMENT PLAN plan

AGRELIANT GENETICS 401K RETIREMENT PLAN 401k Plan overview

Plan Name	AGRELIANT GENETICS 401K RETIREMENT PLAN
Plan identification number	001

AGRELIANT GENETICS 401K RETIREMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Participant-directed brokerage accounts provided as an investment option under the plan.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Plan covering Self-Employed individuals.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

AGRELIANT GENETICS, LLC has sponsored the creation of one or more 401k plans.

Company Name: AGRELIANT GENETICS, LLC

Employer identification number (EIN): 352109761

NAIC Classification: 115110

Additional information about AGRELIANT GENETICS, LLC

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 3241250

More information about AGRELIANT GENETICS, LLC

Form 5500 Filing Information

Submission information for form 5500 for 401k plan AGRELIANT GENETICS 401K RETIREMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 JANAE WELLINGTON PHILIP NORDEEN 2018-07-31
001 2017-01-01 PHILIP NORDEEN JANAE WELLINGTON 2019-02-01
001 2016-01-01 JANAE WELLINGTON PHILIP NORDEEN 2017-09-21
001 2016-01-01 JANAE WELLINGTON 2019-02-01
001 2015-01-01 EDWARD GERMAIN JANAE WELLINGTON 2016-08-01
001 2014-01-01 EDWARD GERMAIN JANAE WELLINGTON 2015-07-30
001 2013-01-01 JANAE WELLINGTON EDWARD M GERMAIN 2014-07-31
001 2012-01-01 WILLIAM EISLER EDWARD GERMAIN 2013-07-26
001 2011-01-01 WILLIAM EISLER EDWARD GERMAIN 2012-07-31
001 2010-01-01 WILLIAM EISLER EDWARD GERMAIN 2011-07-27
001 2009-01-01 WILLIAM R. EISLER EDWARD M. GERMAIN 2010-08-10
001 2009-01-01 WILLIAM R. EISLER EDWARD M. GERMAIN 2010-08-10

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	JANAE WELLINGTON	PHILIP NORDEEN	2018-07-31
001	2017-01-01	PHILIP NORDEEN	JANAE WELLINGTON	2019-02-01
001	2016-01-01	JANAE WELLINGTON	PHILIP NORDEEN	2017-09-21
001	2016-01-01		JANAE WELLINGTON	2019-02-01
001	2015-01-01	EDWARD GERMAIN	JANAE WELLINGTON	2016-08-01
001	2014-01-01	EDWARD GERMAIN	JANAE WELLINGTON	2015-07-30
001	2013-01-01	JANAE WELLINGTON	EDWARD M GERMAIN	2014-07-31
001	2012-01-01	WILLIAM EISLER	EDWARD GERMAIN	2013-07-26
001	2011-01-01	WILLIAM EISLER	EDWARD GERMAIN	2012-07-31
001	2010-01-01	WILLIAM EISLER	EDWARD GERMAIN	2011-07-27
001	2009-01-01	WILLIAM R. EISLER	EDWARD M. GERMAIN	2010-08-10
001	2009-01-01	WILLIAM R. EISLER	EDWARD M. GERMAIN	2010-08-10

Plan Statistics for AGRELIANT GENETICS 401K RETIREMENT PLAN

401k plan membership statisitcs for AGRELIANT GENETICS 401K RETIREMENT PLAN

Measure Date Value
2022: AGRELIANT GENETICS 401K RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,100
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 754
Number of retired or separated participants receiving benefits 2022-01-01 8
Number of other retired or separated participants entitled to future benefits 2022-01-01 333
Total of all active and inactive participants 2022-01-01 1,095
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 2
Total participants 2022-01-01 1,097
Number of participants with account balances 2022-01-01 1,082
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: AGRELIANT GENETICS 401K RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,189
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 780
Number of retired or separated participants receiving benefits 2021-01-01 9
Number of other retired or separated participants entitled to future benefits 2021-01-01 309
Total of all active and inactive participants 2021-01-01 1,098
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 2
Total participants 2021-01-01 1,100
Number of participants with account balances 2021-01-01 1,095
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 52
2020: AGRELIANT GENETICS 401K RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,144
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 807
Number of retired or separated participants receiving benefits 2020-01-01 3
Number of other retired or separated participants entitled to future benefits 2020-01-01 379
Total of all active and inactive participants 2020-01-01 1,189
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 1,189
Number of participants with account balances 2020-01-01 1,183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 4
2019: AGRELIANT GENETICS 401K RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,115
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 825
Number of retired or separated participants receiving benefits 2019-01-01 7
Number of other retired or separated participants entitled to future benefits 2019-01-01 310
Total of all active and inactive participants 2019-01-01 1,142
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 2
Total participants 2019-01-01 1,144
Number of participants with account balances 2019-01-01 1,143
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 30
2018: AGRELIANT GENETICS 401K RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 1,125
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 803
Number of retired or separated participants receiving benefits 2018-01-01 7
Number of other retired or separated participants entitled to future benefits 2018-01-01 290
Total of all active and inactive participants 2018-01-01 1,100
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 1,100
Number of participants with account balances 2018-01-01 1,067
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 27
2017: AGRELIANT GENETICS 401K RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 1,041
Number of retired or separated participants receiving benefits 2017-01-01 5
Number of other retired or separated participants entitled to future benefits 2017-01-01 1,065
Total of all active and inactive participants 2017-01-01 1,070
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 1,070
Number of participants with account balances 2017-01-01 1,070
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 8
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 789
2016: AGRELIANT GENETICS 401K RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 1,357
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 785
Number of retired or separated participants receiving benefits 2016-01-01 3
Number of other retired or separated participants entitled to future benefits 2016-01-01 253
Total of all active and inactive participants 2016-01-01 1,041
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 1,041
Number of participants with account balances 2016-01-01 1,041
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 29
2015: AGRELIANT GENETICS 401K RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 1,137
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 1,116
Number of retired or separated participants receiving benefits 2015-01-01 4
Number of other retired or separated participants entitled to future benefits 2015-01-01 236
Total of all active and inactive participants 2015-01-01 1,356
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 1
Total participants 2015-01-01 1,357
Number of participants with account balances 2015-01-01 994
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 15
2014: AGRELIANT GENETICS 401K RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 928
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 893
Number of retired or separated participants receiving benefits 2014-01-01 4
Number of other retired or separated participants entitled to future benefits 2014-01-01 239
Total of all active and inactive participants 2014-01-01 1,136
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 1
Total participants 2014-01-01 1,137
Number of participants with account balances 2014-01-01 936
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 22
2013: AGRELIANT GENETICS 401K RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 884
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 712
Number of retired or separated participants receiving benefits 2013-01-01 4
Number of other retired or separated participants entitled to future benefits 2013-01-01 212
Total of all active and inactive participants 2013-01-01 928
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 928
Number of participants with account balances 2013-01-01 893
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: AGRELIANT GENETICS 401K RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 830
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 684
Number of retired or separated participants receiving benefits 2012-01-01 4
Number of other retired or separated participants entitled to future benefits 2012-01-01 196
Total of all active and inactive participants 2012-01-01 884
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 884
Number of participants with account balances 2012-01-01 849
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 12
2011: AGRELIANT GENETICS 401K RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 787
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 648
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 182
Total of all active and inactive participants 2011-01-01 830
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 830
Number of participants with account balances 2011-01-01 807
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 12
2010: AGRELIANT GENETICS 401K RETIREMENT PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 740
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 603
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 184
Total of all active and inactive participants 2010-01-01 787
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 787
Number of participants with account balances 2010-01-01 787
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 15
2009: AGRELIANT GENETICS 401K RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 741
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 557
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 183
Total of all active and inactive participants 2009-01-01 740
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 740
Number of participants with account balances 2009-01-01 740
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 27

Measure	Date	Value
2022: AGRELIANT GENETICS 401K RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,100
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	754
Number of retired or separated participants receiving benefits	2022-01-01	8
Number of other retired or separated participants entitled to future benefits	2022-01-01	333
Total of all active and inactive participants	2022-01-01	1,095
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	2
Total participants	2022-01-01	1,097
Number of participants with account balances	2022-01-01	1,082
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: AGRELIANT GENETICS 401K RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,189
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	780
Number of retired or separated participants receiving benefits	2021-01-01	9
Number of other retired or separated participants entitled to future benefits	2021-01-01	309
Total of all active and inactive participants	2021-01-01	1,098
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	2
Total participants	2021-01-01	1,100
Number of participants with account balances	2021-01-01	1,095
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	52
2020: AGRELIANT GENETICS 401K RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,144
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	807
Number of retired or separated participants receiving benefits	2020-01-01	3
Number of other retired or separated participants entitled to future benefits	2020-01-01	379
Total of all active and inactive participants	2020-01-01	1,189
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	1,189
Number of participants with account balances	2020-01-01	1,183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	4
2019: AGRELIANT GENETICS 401K RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,115
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	825
Number of retired or separated participants receiving benefits	2019-01-01	7
Number of other retired or separated participants entitled to future benefits	2019-01-01	310
Total of all active and inactive participants	2019-01-01	1,142
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	2
Total participants	2019-01-01	1,144
Number of participants with account balances	2019-01-01	1,143
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	30
2018: AGRELIANT GENETICS 401K RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	1,125
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	803
Number of retired or separated participants receiving benefits	2018-01-01	7
Number of other retired or separated participants entitled to future benefits	2018-01-01	290
Total of all active and inactive participants	2018-01-01	1,100
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	1,100
Number of participants with account balances	2018-01-01	1,067
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	27
2017: AGRELIANT GENETICS 401K RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	1,041
Number of retired or separated participants receiving benefits	2017-01-01	5
Number of other retired or separated participants entitled to future benefits	2017-01-01	1,065
Total of all active and inactive participants	2017-01-01	1,070
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	1,070
Number of participants with account balances	2017-01-01	1,070
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	8
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	789
2016: AGRELIANT GENETICS 401K RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	1,357
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	785
Number of retired or separated participants receiving benefits	2016-01-01	3
Number of other retired or separated participants entitled to future benefits	2016-01-01	253
Total of all active and inactive participants	2016-01-01	1,041
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	1,041
Number of participants with account balances	2016-01-01	1,041
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	29
2015: AGRELIANT GENETICS 401K RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	1,137
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	1,116
Number of retired or separated participants receiving benefits	2015-01-01	4
Number of other retired or separated participants entitled to future benefits	2015-01-01	236
Total of all active and inactive participants	2015-01-01	1,356
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	1
Total participants	2015-01-01	1,357
Number of participants with account balances	2015-01-01	994
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	15
2014: AGRELIANT GENETICS 401K RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	928
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	893
Number of retired or separated participants receiving benefits	2014-01-01	4
Number of other retired or separated participants entitled to future benefits	2014-01-01	239
Total of all active and inactive participants	2014-01-01	1,136
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	1
Total participants	2014-01-01	1,137
Number of participants with account balances	2014-01-01	936
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	22
2013: AGRELIANT GENETICS 401K RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	884
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	712
Number of retired or separated participants receiving benefits	2013-01-01	4
Number of other retired or separated participants entitled to future benefits	2013-01-01	212
Total of all active and inactive participants	2013-01-01	928
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	928
Number of participants with account balances	2013-01-01	893
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: AGRELIANT GENETICS 401K RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	830
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	684
Number of retired or separated participants receiving benefits	2012-01-01	4
Number of other retired or separated participants entitled to future benefits	2012-01-01	196
Total of all active and inactive participants	2012-01-01	884
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	884
Number of participants with account balances	2012-01-01	849
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	12
2011: AGRELIANT GENETICS 401K RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	787
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	648
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	182
Total of all active and inactive participants	2011-01-01	830
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	830
Number of participants with account balances	2011-01-01	807
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	12
2010: AGRELIANT GENETICS 401K RETIREMENT PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	740
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	603
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	184
Total of all active and inactive participants	2010-01-01	787
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	787
Number of participants with account balances	2010-01-01	787
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	15
2009: AGRELIANT GENETICS 401K RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	741
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	557
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	183
Total of all active and inactive participants	2009-01-01	740
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	740
Number of participants with account balances	2009-01-01	740
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	27

Financial Data on AGRELIANT GENETICS 401K RETIREMENT PLAN

Measure	Date	Value
2022 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2022 401k financial data
Unrealized appreciation/depreciation of real estate assets	2022-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2022-12-31	$-369,677
Total unrealized appreciation/depreciation of assets	2022-12-31	$-369,677
Total transfer of assets to this plan	2022-12-31	$0
Total transfer of assets from this plan	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Expenses. Interest paid	2022-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-13,099,267
Total loss/gain on sale of assets	2022-12-31	$-15,835
Total of all expenses incurred	2022-12-31	$20,045,702
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$20,090,921
Expenses. Certain deemed distributions of participant loans	2022-12-31	$0
Value of total corrective distributions	2022-12-31	$3,389
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$11,455,142
Value of total assets at end of year	2022-12-31	$131,310,943
Value of total assets at beginning of year	2022-12-31	$164,455,912
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$-48,608
Total income from rents	2022-12-31	$0
Total interest from all sources	2022-12-31	$46,808
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$6,174,512
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$6,153,614
Assets. Real estate other than employer real property at end of year	2022-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2022-12-31	$0
Administrative expenses professional fees incurred	2022-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2022-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2022-12-31	$0
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$6,109,487
Participant contributions at end of year	2022-12-31	$997,996
Participant contributions at beginning of year	2022-12-31	$882,768
Participant contributions at end of year	2022-12-31	$183,768
Participant contributions at beginning of year	2022-12-31	$172,107
Assets. Other investments not covered elsewhere at end of year	2022-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2022-12-31	$61
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$1,065,080
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$0
Assets. Loans (other than to participants) at end of year	2022-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2022-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2022-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2022-12-31	$0
Other income not declared elsewhere	2022-12-31	$0
Administrative expenses (other) incurred	2022-12-31	$-48,608
Liabilities. Value of operating payables at end of year	2022-12-31	$0
Liabilities. Value of operating payables at beginning of year	2022-12-31	$0
Total non interest bearing cash at end of year	2022-12-31	$126,102
Total non interest bearing cash at beginning of year	2022-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Income. Non cash contributions	2022-12-31	$0
Value of net income/loss	2022-12-31	$-33,144,969
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$131,310,943
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$164,455,912
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Assets. partnership/joint venture interests at end of year	2022-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2022-12-31	$0
Investment advisory and management fees	2022-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$119,066,109
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$152,314,135
Value of interest in pooled separate accounts at end of year	2022-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$0
Interest on participant loans	2022-12-31	$43,790
Income. Interest from loans (other than to participants)	2022-12-31	$0
Interest earned on other investments	2022-12-31	$0
Income. Interest from US Government securities	2022-12-31	$0
Income. Interest from corporate debt instruments	2022-12-31	$0
Value of interest in master investment trust accounts at end of year	2022-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2022-12-31	$0
Value of interest in common/collective trusts at end of year	2022-12-31	$9,125,698
Value of interest in common/collective trusts at beginning of year	2022-12-31	$9,010,321
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-12-31	$273,170
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$158,955
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$158,955
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$3,018
Assets. Value of investments in 103.12 investment entities at end of year	2022-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2022-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2022-12-31	$0
Asset value of US Government securities at end of year	2022-12-31	$0
Asset value of US Government securities at beginning of year	2022-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-30,610,883
Net investment gain/loss from pooled separate accounts	2022-12-31	$0
Net investment gain or loss from common/collective trusts	2022-12-31	$220,666
Net gain/loss from 103.12 investment entities	2022-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Assets. Invements in employer securities at end of year	2022-12-31	$0
Assets. Invements in employer securities at beginning of year	2022-12-31	$0
Assets. Value of employer real property at end of year	2022-12-31	$0
Assets. Value of employer real property at beginning of year	2022-12-31	$0
Contributions received in cash from employer	2022-12-31	$4,280,575
Employer contributions (assets) at end of year	2022-12-31	$187,998
Employer contributions (assets) at beginning of year	2022-12-31	$190,769
Income. Dividends from preferred stock	2022-12-31	$0
Income. Dividends from common stock	2022-12-31	$20,898
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$20,090,921
Asset. Corporate debt instrument preferred debt at end of year	2022-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2022-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2022-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2022-12-31	$0
Contract administrator fees	2022-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2022-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2022-12-31	$1,350,102
Assets. Corporate common stocks other than exployer securities at beginning of year	2022-12-31	$1,726,796
Liabilities. Value of benefit claims payable at end of year	2022-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2022-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2022-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2022-12-31	$0
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Aggregate proceeds on sale of assets	2022-12-31	$1,283,370
Aggregate carrying amount (costs) on sale of assets	2022-12-31	$1,299,205
Liabilities. Value of acquisition indebtedness at end of year	2022-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2022-12-31	$0
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	BLUE & CO.
Accountancy firm EIN	2022-12-31	351178661
2021 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2021 401k financial data
Unrealized appreciation/depreciation of real estate assets	2021-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2021-12-31	$196,083
Total unrealized appreciation/depreciation of assets	2021-12-31	$196,083
Total transfer of assets to this plan	2021-12-31	$0
Total transfer of assets from this plan	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Expenses. Interest paid	2021-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$33,203,271
Total loss/gain on sale of assets	2021-12-31	$70,310
Total of all expenses incurred	2021-12-31	$17,220,195
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$17,261,244
Expenses. Certain deemed distributions of participant loans	2021-12-31	$0
Value of total corrective distributions	2021-12-31	$6,643
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$11,195,264
Value of total assets at end of year	2021-12-31	$164,455,912
Value of total assets at beginning of year	2021-12-31	$148,472,836
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$-47,692
Total income from rents	2021-12-31	$0
Total interest from all sources	2021-12-31	$47,300
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$14,073,885
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$14,051,699
Assets. Real estate other than employer real property at end of year	2021-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2021-12-31	$0
Administrative expenses professional fees incurred	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2021-12-31	$0
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$5,667,282
Participant contributions at end of year	2021-12-31	$882,768
Participant contributions at beginning of year	2021-12-31	$1,018,536
Participant contributions at end of year	2021-12-31	$172,107
Participant contributions at beginning of year	2021-12-31	$154,163
Assets. Other investments not covered elsewhere at end of year	2021-12-31	$61
Assets. Other investments not covered elsewhere at beginning of year	2021-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$1,421,236
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$0
Assets. Loans (other than to participants) at end of year	2021-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-12-31	$0
Other income not declared elsewhere	2021-12-31	$0
Administrative expenses (other) incurred	2021-12-31	$-47,692
Liabilities. Value of operating payables at end of year	2021-12-31	$0
Liabilities. Value of operating payables at beginning of year	2021-12-31	$0
Total non interest bearing cash at end of year	2021-12-31	$0
Total non interest bearing cash at beginning of year	2021-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Income. Non cash contributions	2021-12-31	$0
Value of net income/loss	2021-12-31	$15,983,076
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$164,455,912
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$148,472,836
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Assets. partnership/joint venture interests at end of year	2021-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2021-12-31	$0
Investment advisory and management fees	2021-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$152,314,135
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$136,795,030
Value of interest in pooled separate accounts at end of year	2021-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$0
Interest on participant loans	2021-12-31	$47,286
Income. Interest from loans (other than to participants)	2021-12-31	$0
Interest earned on other investments	2021-12-31	$0
Income. Interest from US Government securities	2021-12-31	$0
Income. Interest from corporate debt instruments	2021-12-31	$0
Value of interest in master investment trust accounts at end of year	2021-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2021-12-31	$0
Value of interest in common/collective trusts at end of year	2021-12-31	$9,010,321
Value of interest in common/collective trusts at beginning of year	2021-12-31	$8,684,914
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$158,955
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$114,256
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$114,256
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$14
Assets. Value of investments in 103.12 investment entities at end of year	2021-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2021-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2021-12-31	$0
Asset value of US Government securities at end of year	2021-12-31	$0
Asset value of US Government securities at beginning of year	2021-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$7,409,900
Net investment gain/loss from pooled separate accounts	2021-12-31	$0
Net investment gain or loss from common/collective trusts	2021-12-31	$210,529
Net gain/loss from 103.12 investment entities	2021-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Assets. Invements in employer securities at end of year	2021-12-31	$0
Assets. Invements in employer securities at beginning of year	2021-12-31	$0
Assets. Value of employer real property at end of year	2021-12-31	$0
Assets. Value of employer real property at beginning of year	2021-12-31	$0
Contributions received in cash from employer	2021-12-31	$4,106,746
Employer contributions (assets) at end of year	2021-12-31	$190,769
Employer contributions (assets) at beginning of year	2021-12-31	$163,724
Income. Dividends from preferred stock	2021-12-31	$0
Income. Dividends from common stock	2021-12-31	$22,186
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$17,261,244
Asset. Corporate debt instrument preferred debt at end of year	2021-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2021-12-31	$0
Contract administrator fees	2021-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2021-12-31	$1,726,796
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-12-31	$1,542,213
Liabilities. Value of benefit claims payable at end of year	2021-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2021-12-31	$0
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Aggregate proceeds on sale of assets	2021-12-31	$1,531,729
Aggregate carrying amount (costs) on sale of assets	2021-12-31	$1,461,419
Liabilities. Value of acquisition indebtedness at end of year	2021-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2021-12-31	$0
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2021-12-31	351090346
2020 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$145,357
Total unrealized appreciation/depreciation of assets	2020-12-31	$145,357
Total transfer of assets to this plan	2020-12-31	$0
Total transfer of assets from this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Expenses. Interest paid	2020-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$33,386,840
Total loss/gain on sale of assets	2020-12-31	$15,128
Total of all expenses incurred	2020-12-31	$16,506,397
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$16,427,865
Expenses. Certain deemed distributions of participant loans	2020-12-31	$20,973
Value of total corrective distributions	2020-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$9,864,174
Value of total assets at end of year	2020-12-31	$148,472,836
Value of total assets at beginning of year	2020-12-31	$131,592,393
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$57,559
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$56,531
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$4,175,872
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$4,172,647
Assets. Real estate other than employer real property at end of year	2020-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2020-12-31	$0
Administrative expenses professional fees incurred	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$5,464,527
Participant contributions at end of year	2020-12-31	$1,018,536
Participant contributions at beginning of year	2020-12-31	$1,032,002
Participant contributions at end of year	2020-12-31	$154,163
Participant contributions at beginning of year	2020-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2020-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2020-12-31	$1,157,044
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$329,377
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$2,139
Assets. Loans (other than to participants) at end of year	2020-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$241,034
Administrative expenses (other) incurred	2020-12-31	$57,559
Liabilities. Value of operating payables at end of year	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$7,080
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Income. Non cash contributions	2020-12-31	$0
Value of net income/loss	2020-12-31	$16,880,443
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$148,472,836
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$131,592,393
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Assets. partnership/joint venture interests at end of year	2020-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$136,795,030
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$122,992,828
Value of interest in pooled separate accounts at end of year	2020-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$0
Interest on participant loans	2020-12-31	$56,526
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$0
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in master investment trust accounts at end of year	2020-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$8,684,914
Value of interest in common/collective trusts at beginning of year	2020-12-31	$6,401,298
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$114,256
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$2
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$2
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$5
Assets. Value of investments in 103.12 investment entities at end of year	2020-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Asset value of US Government securities at end of year	2020-12-31	$0
Asset value of US Government securities at beginning of year	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$18,701,020
Net investment gain/loss from pooled separate accounts	2020-12-31	$0
Net investment gain or loss from common/collective trusts	2020-12-31	$187,724
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Assets. Invements in employer securities at end of year	2020-12-31	$0
Assets. Invements in employer securities at beginning of year	2020-12-31	$0
Assets. Value of employer real property at end of year	2020-12-31	$0
Assets. Value of employer real property at beginning of year	2020-12-31	$0
Contributions received in cash from employer	2020-12-31	$4,070,270
Employer contributions (assets) at end of year	2020-12-31	$163,724
Employer contributions (assets) at beginning of year	2020-12-31	$0
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$3,225
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$16,427,865
Asset. Corporate debt instrument preferred debt at end of year	2020-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2020-12-31	$0
Contract administrator fees	2020-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Assets. Corporate common stocks other than exployer securities at end of year	2020-12-31	$1,542,213
Assets. Corporate common stocks other than exployer securities at beginning of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$567,425
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$552,297
Liabilities. Value of acquisition indebtedness at end of year	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2020-12-31	351090346
2019 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$36,501,921
Total of all expenses incurred	2019-12-31	$10,740,571
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$10,632,119
Expenses. Certain deemed distributions of participant loans	2019-12-31	$1,268
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$10,108,396
Value of total assets at end of year	2019-12-31	$131,592,393
Value of total assets at beginning of year	2019-12-31	$105,831,043
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$107,184
Total interest from all sources	2019-12-31	$54,008
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$1,702,430
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$1,702,430
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$4,979,084
Participant contributions at end of year	2019-12-31	$1,032,002
Participant contributions at beginning of year	2019-12-31	$1,021,557
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$1,157,044
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$992,671
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$1,445,136
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$2,139
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$1,351
Other income not declared elsewhere	2019-12-31	$48,576
Administrative expenses (other) incurred	2019-12-31	$107,184
Total non interest bearing cash at end of year	2019-12-31	$7,080
Total non interest bearing cash at beginning of year	2019-12-31	$7,080
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$25,761,350
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$131,592,393
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$105,831,043
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$122,992,828
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$98,216,475
Interest on participant loans	2019-12-31	$54,004
Value of interest in common/collective trusts at end of year	2019-12-31	$6,401,298
Value of interest in common/collective trusts at beginning of year	2019-12-31	$5,591,182
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$2
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$727
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$727
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$4
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$24,444,935
Net investment gain or loss from common/collective trusts	2019-12-31	$143,576
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$3,684,176
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$10,632,119
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	No
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2019-12-31	351090346
2018 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2018 401k financial data
Total income from all sources (including contributions)	2018-12-31	$3,054,946
Total of all expenses incurred	2018-12-31	$9,989,610
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$9,883,618
Expenses. Certain deemed distributions of participant loans	2018-12-31	$812
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$8,994,903
Value of total assets at end of year	2018-12-31	$105,831,043
Value of total assets at beginning of year	2018-12-31	$112,765,707
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$105,180
Total interest from all sources	2018-12-31	$46,812
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$1,963,572
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$1,963,572
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$4,883,539
Participant contributions at end of year	2018-12-31	$1,021,557
Participant contributions at beginning of year	2018-12-31	$932,278
Assets. Other investments not covered elsewhere at end of year	2018-12-31	$992,671
Assets. Other investments not covered elsewhere at beginning of year	2018-12-31	$920,701
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$429,373
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$1,351
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Other income not declared elsewhere	2018-12-31	$-57,105
Administrative expenses (other) incurred	2018-12-31	$105,180
Total non interest bearing cash at end of year	2018-12-31	$7,080
Total non interest bearing cash at beginning of year	2018-12-31	$7,080
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-6,934,664
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$105,831,043
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$112,765,707
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$98,216,475
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$105,003,119
Interest on participant loans	2018-12-31	$46,810
Value of interest in common/collective trusts at end of year	2018-12-31	$5,591,182
Value of interest in common/collective trusts at beginning of year	2018-12-31	$5,902,527
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$727
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$2
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$2
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$2
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-7,893,236
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$3,681,991
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$9,883,618
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2018-12-31	351090346
2017 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2017 401k financial data
Total income from all sources (including contributions)	2017-12-31	$26,611,716
Total of all expenses incurred	2017-12-31	$7,161,718
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$7,059,034
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$8,449,662
Value of total assets at end of year	2017-12-31	$112,765,707
Value of total assets at beginning of year	2017-12-31	$93,315,709
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$102,684
Total interest from all sources	2017-12-31	$43,638
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$2,836,494
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$2,836,494
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$4,602,461
Participant contributions at end of year	2017-12-31	$932,278
Participant contributions at beginning of year	2017-12-31	$1,095,054
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$920,701
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$870,257
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$206,955
Other income not declared elsewhere	2017-12-31	$50,444
Administrative expenses (other) incurred	2017-12-31	$102,684
Total non interest bearing cash at end of year	2017-12-31	$7,080
Total non interest bearing cash at beginning of year	2017-12-31	$7,079
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$19,449,998
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$112,765,707
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$93,315,709
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$105,003,119
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$84,628,365
Income. Interest from loans (other than to participants)	2017-12-31	$43,637
Value of interest in common/collective trusts at end of year	2017-12-31	$5,902,527
Value of interest in common/collective trusts at beginning of year	2017-12-31	$6,714,954
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$2
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$1
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$15,231,478
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$3,640,246
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$7,059,034
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	No
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2017-12-31	351090346
2016 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2016 401k financial data
Total income from all sources (including contributions)	2016-12-31	$14,174,916
Total of all expenses incurred	2016-12-31	$3,824,022
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$3,667,266
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$8,199,656
Value of total assets at end of year	2016-12-31	$93,315,709
Value of total assets at beginning of year	2016-12-31	$82,964,815
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$156,756
Total interest from all sources	2016-12-31	$45,207
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$1,530,114
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$1,530,114
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$4,385,091
Participant contributions at end of year	2016-12-31	$1,095,054
Participant contributions at beginning of year	2016-12-31	$975,814
Assets. Other investments not covered elsewhere at end of year	2016-12-31	$870,257
Assets. Other investments not covered elsewhere at beginning of year	2016-12-31	$739,046
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$242,863
Administrative expenses (other) incurred	2016-12-31	$156,756
Total non interest bearing cash at end of year	2016-12-31	$7,079
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$10,350,894
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$93,315,709
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$82,964,815
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$84,628,365
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$75,650,511
Interest on participant loans	2016-12-31	$45,207
Value of interest in common/collective trusts at end of year	2016-12-31	$6,714,954
Value of interest in common/collective trusts at beginning of year	2016-12-31	$5,599,444
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$4,399,939
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$3,571,702
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$3,667,266
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-12-31	Yes
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2016-12-31	351090346
2015 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$7,270,658
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$5,450,636
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$5,274,806
Expenses. Certain deemed distributions of participant loans	2015-12-31	$72,268
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$7,263,831
Value of total assets at end of year	2015-12-31	$82,964,815
Value of total assets at beginning of year	2015-12-31	$81,144,793
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$103,562
Total interest from all sources	2015-12-31	$46,151
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$4,169,601
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$4,169,601
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$3,937,940
Participant contributions at end of year	2015-12-31	$975,814
Participant contributions at beginning of year	2015-12-31	$1,163,088
Assets. Other investments not covered elsewhere at end of year	2015-12-31	$739,046
Assets. Other investments not covered elsewhere at beginning of year	2015-12-31	$636,322
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$142,509
Administrative expenses (other) incurred	2015-12-31	$103,562
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$1,820,022
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$82,964,815
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$81,144,793
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$75,650,511
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$73,763,463
Interest on participant loans	2015-12-31	$46,151
Value of interest in common/collective trusts at end of year	2015-12-31	$5,599,444
Value of interest in common/collective trusts at beginning of year	2015-12-31	$5,581,920
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-4,198,618
Net investment gain or loss from common/collective trusts	2015-12-31	$-10,307
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$3,183,382
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$5,274,806
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2015-12-31	351090346
2014 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$12,840,478
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$5,273,309
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$5,215,211
Expenses. Certain deemed distributions of participant loans	2014-12-31	$-20,384
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$8,247,208
Value of total assets at end of year	2014-12-31	$81,144,793
Value of total assets at beginning of year	2014-12-31	$73,577,624
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$78,482
Total interest from all sources	2014-12-31	$45,964
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$5,186,065
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$5,186,065
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$3,651,382
Participant contributions at end of year	2014-12-31	$1,163,088
Participant contributions at beginning of year	2014-12-31	$927,932
Assets. Other investments not covered elsewhere at end of year	2014-12-31	$636,322
Assets. Other investments not covered elsewhere at beginning of year	2014-12-31	$615,439
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$1,583,078
Other income not declared elsewhere	2014-12-31	$-24,556
Administrative expenses (other) incurred	2014-12-31	$78,482
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$7,567,169
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$81,144,793
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$73,577,624
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$73,763,463
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$65,789,974
Interest on participant loans	2014-12-31	$45,964
Value of interest in common/collective trusts at end of year	2014-12-31	$5,581,920
Value of interest in common/collective trusts at beginning of year	2014-12-31	$6,244,279
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-733,329
Net investment gain or loss from common/collective trusts	2014-12-31	$119,126
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$3,012,748
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$5,215,211
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2014-12-31	351090346
2013 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$19,369,720
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$3,573,165
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$3,503,103
Expenses. Certain deemed distributions of participant loans	2013-12-31	$21,368
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$6,520,878
Value of total assets at end of year	2013-12-31	$73,577,624
Value of total assets at beginning of year	2013-12-31	$57,781,069
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$48,694
Total interest from all sources	2013-12-31	$38,017
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$3,560,304
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$3,560,304
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$3,489,102
Participant contributions at end of year	2013-12-31	$927,932
Participant contributions at beginning of year	2013-12-31	$949,286
Assets. Other investments not covered elsewhere at end of year	2013-12-31	$615,439
Assets. Other investments not covered elsewhere at beginning of year	2013-12-31	$537,015
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$130,933
Other income not declared elsewhere	2013-12-31	$-29,556
Administrative expenses (other) incurred	2013-12-31	$48,694
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$15,796,555
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$73,577,624
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$57,781,069
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$65,789,974
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$50,977,501
Interest on participant loans	2013-12-31	$38,017
Value of interest in common/collective trusts at end of year	2013-12-31	$6,244,279
Value of interest in common/collective trusts at beginning of year	2013-12-31	$5,311,841
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$5,426
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$5,426
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$9,105,288
Net investment gain or loss from common/collective trusts	2013-12-31	$174,789
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$2,900,843
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$3,503,103
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	KATZ SAPPER & MILLER LLP
Accountancy firm EIN	2013-12-31	351090346
2012 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$12,445,201
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$2,267,479
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$2,189,274
Expenses. Certain deemed distributions of participant loans	2012-12-31	$445
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$6,145,527
Value of total assets at end of year	2012-12-31	$57,781,069
Value of total assets at beginning of year	2012-12-31	$47,603,347
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$77,760
Total interest from all sources	2012-12-31	$31,493
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$1,560,883
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$1,560,883
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$3,202,461
Participant contributions at end of year	2012-12-31	$949,286
Participant contributions at beginning of year	2012-12-31	$732,529
Assets. Other investments not covered elsewhere at end of year	2012-12-31	$537,015
Assets. Other investments not covered elsewhere at beginning of year	2012-12-31	$488,141
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$264,203
Other income not declared elsewhere	2012-12-31	$31,501
Administrative expenses (other) incurred	2012-12-31	$77,760
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$10,177,722
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$57,781,069
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$47,603,347
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$50,977,501
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$41,871,266
Interest on participant loans	2012-12-31	$31,493
Value of interest in common/collective trusts at end of year	2012-12-31	$5,311,841
Value of interest in common/collective trusts at beginning of year	2012-12-31	$4,501,981
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$5,426
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$9,430
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$9,430
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$4,580,872
Net investment gain or loss from common/collective trusts	2012-12-31	$94,925
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$2,678,863
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$2,189,274
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	CLIFTONLARSONALLEN LLP
Accountancy firm EIN	2012-12-31	410746749
2011 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$3,668,381
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$2,157,190
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$2,097,312
Expenses. Certain deemed distributions of participant loans	2011-12-31	$445
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$5,644,312
Value of total assets at end of year	2011-12-31	$47,603,347
Value of total assets at beginning of year	2011-12-31	$46,092,156
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$59,433
Total interest from all sources	2011-12-31	$32,498
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$1,384,669
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$1,384,669
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$3,007,272
Participant contributions at end of year	2011-12-31	$732,529
Participant contributions at beginning of year	2011-12-31	$701,967
Assets. Other investments not covered elsewhere at end of year	2011-12-31	$488,141
Assets. Other investments not covered elsewhere at beginning of year	2011-12-31	$703,409
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$123,836
Other income not declared elsewhere	2011-12-31	$-186,924
Administrative expenses (other) incurred	2011-12-31	$59,433
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$1,511,191
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$47,603,347
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$46,092,156
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$41,871,266
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$41,322,747
Interest on participant loans	2011-12-31	$32,498
Value of interest in common/collective trusts at end of year	2011-12-31	$4,501,981
Value of interest in common/collective trusts at beginning of year	2011-12-31	$3,352,762
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2011-12-31	$9,430
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2011-12-31	$11,271
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2011-12-31	$11,271
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-3,331,671
Net investment gain or loss from common/collective trusts	2011-12-31	$125,497
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$2,513,204
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$2,097,312
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	CLIFTON LARSON ALLEN
Accountancy firm EIN	2011-12-31	410746749
2010 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$11,082,841
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$2,942,922
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$2,893,254
Expenses. Certain deemed distributions of participant loans	2010-12-31	$446
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$5,209,186
Value of total assets at end of year	2010-12-31	$46,092,156
Value of total assets at beginning of year	2010-12-31	$37,952,237
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$49,222
Total interest from all sources	2010-12-31	$27,936
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$932,053
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$932,053
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$2,717,313
Participant contributions at end of year	2010-12-31	$701,967
Participant contributions at beginning of year	2010-12-31	$425,807
Participant contributions at end of year	2010-12-31	$0
Participant contributions at beginning of year	2010-12-31	$106
Assets. Other investments not covered elsewhere at end of year	2010-12-31	$703,409
Assets. Other investments not covered elsewhere at beginning of year	2010-12-31	$485,154
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$235,525
Value of other receiveables (less allowance for doubtful accounts) at end of year	2010-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2010-12-31	$72
Other income not declared elsewhere	2010-12-31	$216,057
Administrative expenses (other) incurred	2010-12-31	$49,222
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$8,139,919
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$46,092,156
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$37,952,237
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$41,322,747
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$33,870,136
Interest on participant loans	2010-12-31	$27,936
Value of interest in common/collective trusts at end of year	2010-12-31	$3,352,762
Value of interest in common/collective trusts at beginning of year	2010-12-31	$3,163,437
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$11,271
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$7,170
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$7,170
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$4,567,975
Net investment gain or loss from common/collective trusts	2010-12-31	$129,634
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$2,256,348
Employer contributions (assets) at end of year	2010-12-31	$0
Employer contributions (assets) at beginning of year	2010-12-31	$355
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$2,893,254
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	CLIFTON GUNDERSON LLP
Accountancy firm EIN	2010-12-31	370802863
2009 : AGRELIANT GENETICS 401K RETIREMENT PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for AGRELIANT GENETICS 401K RETIREMENT PLAN

2022: AGRELIANT GENETICS 401K RETIREMENT PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: AGRELIANT GENETICS 401K RETIREMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: AGRELIANT GENETICS 401K RETIREMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	Yes
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: AGRELIANT GENETICS 401K RETIREMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Mulitple employer plan
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: AGRELIANT GENETICS 401K RETIREMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Mulitple employer plan
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: AGRELIANT GENETICS 401K RETIREMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Mulitple employer plan
2017-01-01	Submission has been amended	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: AGRELIANT GENETICS 401K RETIREMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Mulitple employer plan
2016-01-01	Submission has been amended	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: AGRELIANT GENETICS 401K RETIREMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Mulitple employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: AGRELIANT GENETICS 401K RETIREMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: AGRELIANT GENETICS 401K RETIREMENT PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	Yes
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: AGRELIANT GENETICS 401K RETIREMENT PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: AGRELIANT GENETICS 401K RETIREMENT PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: AGRELIANT GENETICS 401K RETIREMENT PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: AGRELIANT GENETICS 401K RETIREMENT PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	AGRELIANT GENETICS, LLC
Employer identification number (EIN):	352109761
NAIC Classification:	115110

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	3241250